4
Changes in Ownership
Pharvaris N.V. Filed Acc 0001193125-26-175965
Chief Medical Officer sold 7,101 shares at an average $30.05 ($213,405)
- Chief Medical Officer acquired 7,101 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lu Peng · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,001 | $2.59 | $18,133 | 73,084 | D |
| 2026-04-22 | Sale : show line 2 in the form 10b5-1 | −7,001 | $30.05 | $210,402 | 66,083 | D |
| 2026-04-23 | Exercise or conversion : show line 3 in the form 10b5-1 | +100 | $2.59 | $259 | 66,183 | D |
| 2026-04-23 | Sale : show line 4 in the form 10b5-1 | −100 | $30.03 | $3,003 | 66,083 | D |
| Open-market sales · 7,101 sh · avg $30.05 · $213,405 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-22 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −7,001 | 106,307 | D |
| 2026-04-23 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −100 | 106,207 | D |
Loading xslF345X06/ownership.xml…